Newbridge Financial Services Group’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-16
| Closed | -$34 | – | 1221 |
|
|
2023
Q3 | $34 | Hold |
16
| – | – | ﹤0.01% | 1267 |
|
|
2023
Q2 | $76 | Hold |
16
| – | – | ﹤0.01% | 1308 |
|
|
2023
Q1 | $91 | Hold |
16
| – | – | ﹤0.01% | 1366 |
|
|
2022
Q4 | $161 | Hold |
16
| – | – | ﹤0.01% | 1392 |
|
|
2022
Q3 | $0 | Hold |
16
| – | – | ﹤0.01% | 1412 |
|
|
2022
Q2 | $0 | Hold |
16
| – | – | ﹤0.01% | 1403 |
|
|
2022
Q1 | $1K | Hold |
16
| – | – | ﹤0.01% | 1372 |
|
|
2021
Q4 | $1K | Hold |
16
| – | – | ﹤0.01% | 1319 |
|
|
2021
Q3 | $1K | Hold |
16
| – | – | ﹤0.01% | 1251 |
|
|
2021
Q2 | $1K | Hold |
16
| – | – | ﹤0.01% | 1349 |
|
|
2021
Q1 | $1K | Buy |
+16
| New | +$1K | ﹤0.01% | 1266 |
|